Isolation and determination of four potential antimicrobial components from Pseudomonas aeruginosa extracts

Int J Med Sci. 2017 Nov 2;14(13):1368-1374. doi: 10.7150/ijms.18896. eCollection 2017.

Abstract

Background:Pseudomonas aeruginosa can cause disease and also can be isolated from the skin of healthy people. Additionally, it exhibits certain antimicrobial effects against other microorganisms.Methods: We collected 60 strains of P. aeruginosa and screened their antimicrobial effects against Staphylococcus aureus (ATCC 25923) using the filter paper-disk method, the cross-streaking method and the co-culture method and then evaluated the antimicrobial activity of the chloroform-isolated S. aureus extracts against methicillin-resistant S. aureus (MRSA, Gram-positive cocci), vancomycin intermediate-resistant S. aureus (VISA, Gram-positive cocci), Corynebacterium spp. (CS, Gram-positive bacilli), Acinetobacter baumannii (AB, Gram-negative bacilli), Moraxella catarrhalis (MC, Gram-negative diplococcus), Candida albicans (CA, fungi), Candida tropicalis (CT, fungi), Candida glabrata (CG, fungi) and Candida parapsilosis (CP, fungi). Results: The PA06 and PA46 strains have strong antimicrobial effects. High-performance liquid chromatography (HPLC) analysis revealed that the major components of PA06 and PA46 that exhibit antimicrobial activity are functionally similar to phenazine-1-carboxylic acid (PCA) and pyocyanin. Preparative HPLC was performed to separate and isolate the 4 major potential antimicrobial components: PA06ER10, PA06ER16, PA06ER23 and PA06ER31. Further, the molecular masses of PA06ER10 (260.1), PA06ER16 (274.1), PA06ER23 (286.1) and PA06ER31 (318.2) were determined by electrospray ionization (ESI) mass spectrometry. Conclusion:P. aeruginosa can produce small molecules with potential antimicrobial activities against MRSA, VISA, CS, MC, CA, CT, CG and CP but not against AB.

Keywords: PCA; Pseudomonas aeruginosa; Staphylococcus aureus; antimicrobial effects; pyocyanin..

MeSH terms

  • Acinetobacter baumannii / drug effects
  • Acinetobacter baumannii / pathogenicity
  • Anti-Infective Agents / isolation & purification*
  • Anti-Infective Agents / pharmacology
  • Candida albicans / drug effects
  • Candida albicans / pathogenicity
  • Cell Extracts / chemistry
  • Cell Extracts / pharmacology
  • Corynebacterium / drug effects
  • Corynebacterium / pathogenicity
  • Humans
  • Methicillin-Resistant Staphylococcus aureus / drug effects*
  • Methicillin-Resistant Staphylococcus aureus / pathogenicity
  • Microbial Sensitivity Tests
  • Pseudomonas aeruginosa / chemistry*
  • Staphylococcal Infections / drug therapy*
  • Staphylococcal Infections / microbiology
  • Vancomycin Resistance / drug effects

Substances

  • Anti-Infective Agents
  • Cell Extracts